Anthropic Adds Novartis CEO Vas Narasimhan to Its Board
Anthropic has added Vas Narasimhan, CEO of Novartis, to its board of directors, marking the first time a pharmaceutical executive has joined the AI startup's governing body. The move comes as Anthropic considers an initial public offering and highlights the company's focus on responsible AI deployment in healthcare.
Tickers: $NVS
Topics: AI governance board appointments executive leadership IPO speculation pharmaceutical industry